Catatan efek · kuartal yang diarsipkan
GPCR
Structure Therapeutics Inc. · Healthcare · Biotechnology
15Pemegang yang dilacak
0Δ pemegang
15.29MSaham yang dipegang
$428.25MNilai yang dilaporkan
+1Posisi baru
−1Keluar
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -9.2% · posisi baru bersih 0.0% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
Kepemilikan dari waktu ke waktu
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 66 | 0 | 29.19M | $1.56B | +7 | −7 |
| Q1 2026 | 68 | -4 | 35.35M | $1.72B | +6 | −10 |
| Q4 2025 | 71 | 0 | 34.16M | $2.38B | +1 | −1 |
| Q3 2025 | 15 | 0 | 15.29M | $428.25M | +1 | −1 |
| Q2 2025 | 12 | 0 | 15.65M | $324.65M | — | — |
| Q1 2025 | 10 | +2 | 10.69M | $185.13M | +2 | — |
| Q4 2024 | 8 | -1 | 12.53M | $339.72M | — | −1 |
| Q3 2024 | 8 | -3 | 13.88M | $609.35M | — | −3 |
| Q2 2024 | 11 | — | 14.51M | $569.72M | — | — |
Siapa yang memegangnya · Q3 2025
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 2 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.69M | -17.3% | $159.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 5.25M | +6.8% | $147.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Fidelity (FMR) ✦ | 5.25M | +6.8% | $147.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 5.25M | +6.8% | $147.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 5.25M | +6.8% | $147.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.27M | +4.5% | $35.69M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 577.74K | — | $16.18M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 504.40K | — | $14.12M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 443.80K | -66.6% | $12.43M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 443.80K | -66.6% | $12.43M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 407.70K | +23.6% | $11.42M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 289.39K | -18.0% | $8.10M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | BlackRock ✦ (pasif) | 263.94K | +8.5% | $7.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | BlackRock ✦ (pasif) | 263.94K | +8.5% | $7.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 29 | BlackRock ✦ (pasif) | 263.94K | +8.5% | $7.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 182.91K | Baru | $5.12M | 0.0% | New | 1 | SEC ↗ |
| 31 | Renaissance Technologies ✦ | 153.90K | +37.5% | $4.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 116.30K | — | $3.26M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Geode Capital Management ✦ (pasif) | 57.96K | +7.0% | $1.62M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | State Street Global Advisors ✦ (pasif) | 46.02K | +37.5% | $1.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 36.35K | +198.8% | $1.02M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Two Sigma Investments | $5.12M | 0.0% |
Telah keluar
| Marshall Wace | $3.65M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 118.22K saham, $5.19M dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Sering dimiliki bersama
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Aug 06
SC 13G/A — FMR LLC
Asal-usul data: Kepemilikan dari posisi saham biasa 13F yang telah diurai (semesta yang dipantau, set pembanding untuk perubahan); baris orang dalam dari Formulir 3/4/5; kepemilikan saham signifikan dari Jadwal 13D/13G; setiap pengajuan tertaut ke dokumen aslinya di SEC EDGAR.
Periode pelaporan: Q3 2025 ·
Metodologi ·
Dapatkan ini melalui API